Tofacitinib Citrate contains not less than 98.0% and not more than 102.0% of C16H20N6O‧C6H8O7, calculated on dried basis.

共有 1 個藥物證書使用此成份

枸櫞酸托法替布
Tofacitinib Citrate

• 申請商: 新雙隆生技股份有限公司
• 適應症: 免疫抑制劑
• 發證日期: 2021-05-07